Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
0.0971
-0.0028 (-2.80%)
At close: Apr 26, 2024, 3:59 PM
0.0972
+0.0001 (0.10%)
After-hours: Apr 26, 2024, 4:00 PM EDT
Company Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices.
The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information.
It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Heart Test Laboratories, Inc.
| Country | United States |
| Founded | 2007 |
| IPO Date | Jun 15, 2022 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Andrew Simpson |
Contact Details
Address: 550 Reserve St, Suite 360 Southlake, Texas 76092 United States | |
| Phone | 682-237-7781 |
| Website | heartsciences.com |
Stock Details
| Ticker Symbol | HSCS |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001468492 |
| CUSIP Number | 42254E104 |
| ISIN Number | US42254E1047 |
| Employer ID | 26-1344466 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Andrew Simpson | Chief Executive Officer, President and Chairman of the Board of Directors |
| Danielle Watson | Chief Financial Officer and Treasurer |
| Mark T. Hilz | Chief Operating Officer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 18, 2024 | 424B3 | Prospectus |
| Mar 14, 2024 | 8-K | Current Report |
| Mar 14, 2024 | 10-Q | Quarterly Report |
| Mar 13, 2024 | EFFECT | Notice of Effectiveness |
| Mar 11, 2024 | UPLOAD | Filing |
| Mar 5, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Feb 26, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 15, 2024 | 8-K | Current Report |
| Jan 31, 2024 | 8-K | Current Report |
| Jan 25, 2024 | 8-K | Current Report |